Skip to main content
Cyclerion Therapeutics, Inc. logo

Cyclerion Therapeutics, Inc. — Investor Relations & Filings

Ticker · CYCN ISIN · US23255M1053 US Manufacturing
Filings indexed 338 across all filing types
Latest filing 2026-04-30 Annual Report
Country US United States of America
Listing US CYCN

About Cyclerion Therapeutics, Inc.

https://www.cyclerion.com/

Cyclerion Therapeutics, Inc. is a biopharmaceutical company dedicated to advancing personalized therapeutic approaches for neuropsychiatric disorders. The company's primary focus is on developing a treatment for people with Treatment-Resistant Depression (TRD). Its lead program utilizes a method that combines generic anesthetics with a personalized, biofeedback-driven device. This approach is designed to reset dysregulated brainwave patterns by tailoring the therapy to each patient's specific biological needs, offering a new option for individuals who have not responded to traditional treatments.

Recent filings

Filing Released Lang Actions
10-K/A - Cyclerion Therapeutics, Inc. (0001755237) (Filer)
Annual Report
2026-04-30 English
S-4 - Cyclerion Therapeutics, Inc. (0001755237) (Filer)
Registration Form
2026-04-18 English
8-K - Cyclerion Therapeutics, Inc. (0001755237) (Filer)
Regulatory Filings
2026-04-01 English
8-K Filing
Regulatory Filings
2026-02-17 English
8-K
Regulatory Filings
2026-01-06 English
8-K
Regulatory Filings
2025-12-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.